AlphAIAlphAI — Financial news for AI agents
investing.comOCT 211 min read$CME

CME Group A earnings beat by $0.04, revenue topped estimates

CME Group (CME) reported Q3 EPS of $3.02, beating estimates by $0.04, with revenue at $1.74B, exceeding expectations. The stock is up 15.67% over the last 3 months and 10.27% year-over-year. Analysts have revised EPS estimates 7 times positively and 4 times negatively in the last 90 days.

Original reporting
investing.com
Published Oct 21, 2026, 11:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

The earnings beat reinforces CME's growth narrative and could support bullish positioning in the stock.

02

Market read

Earnings beat provides a fresh catalyst for CME stock, likely prompting short-term buying.

03

What to watch

Potential headwinds from regulatory changes or volume pressure were not discussed.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

CME Group is a leading derivatives exchange operator; its earnings are closely watched for insights into market activity.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported Q3 EPS of $3.02, beating estimates by $0.04 and revenue of $1.74B, topping the $1.71B consensus.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The beat on both earnings and revenue for a large-cap exchange operator typically drives short-term buying interest.

Market effects

Sector

Positive earnings may lift sentiment for other financial services and exchange‑related stocks.

Regional

U.S. market participants may see a modest boost in financial sector indices.

Global

Limited to markets tracking U.S. exchange operators.

Counterpoint

What could challenge this read

Some investors may view the modest $0.04 EPS beat as insufficient given high expectations, suggesting caution.

Key entities

  • company
    CME Group

    U.S.-listed derivatives exchange operator (NASDAQ:CME).

Read at source← All news

StoryCME Group posts record Q3 revenue and adjusted EPS beat, but shares dip on guidance concerns

Also covered by

6 outlets

Related articles

OCT 21
$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

marketscreener.com3 min
OCT 21
$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

marketscreener.com2 min
OCT 21
$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.

gurufocus.com2 min